It's not often that a company can have its initial public offering IPO and just two years later be valued at 10 times its original size. But that's just what happened with medical device maker InMode (NASDAQ: INMD). The company's laser-based technology allows for plastic surgery procedures to be performed in a far less invasive manner. Thus far, it has been a resounding success with doctors and patients. And that's not all: InMode hopes to branch out to treat lots of medically necessary conditions like sleep apnea as well. Does that make the stock a buy? In this Dec. 8 video from their YouTube channel, Motley Fool contributors Brian Feroldi and Brian Stoffel discuss these obvious upsides, but uncover some relatively hidden downsides as well. At the end, they reveal how InMode scored on their investing frameworks. 10 stocks we like better than InMode Ltd.When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* They just revealed what they believe are the ten best stocks for investors to buy right now... and InMode Ltd. wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of December 16, 2021 Brian Feroldi has no position in any of the stocks mentioned. Brian Stoffel has no position in any of the stocks mentioned. The Motley Fool owns and recommends InMode Ltd. The Motley Fool has a disclosure policy.Source